Clinical Trial Update: SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days Study [Phase 1]

View source ↗

Summary

Phase 1, placebo-controlled study evaluating absorption, efficacy and tolerability of SMC021A in patients with osteoarthritis over 14 days. The trial has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• SMC021A

Snippet

Sponsor: Nordic Bioscience A/S | Conditions: Osteoarthritis | Phase 1 | Status: COMPLETED